-
Volastra Therapeutics Announces Appointment of David P. Southwell as Chief Executive Officer
27 May 2025 11:19 GMT
… career leading innovative biotechnology and pharmaceutical companies. He most recently … executive roles as CFO at Human Genome Sciences through its acquisition by GlaxoSmithKline … of PTC Therapeutics and Rocket Pharmaceuticals.
Mr. Southwell succeeds Charles …
-
Strengthening Your Compendial Strategy
23 Apr 2025 00:25 GMT
… an extensive career in the pharmaceutical industry where she tested and … , Treasurer of the New Jersey Pharmaceutical Quality Control Association, and she … in the biotech and pharmaceutical industries. At Medimmune, Human Genome Sciences, and Bristol Myers …
-
Human Genome Sciences Raises $100 Million from Private Offering
21 Sep 2019 11:05 GMT
… adjustment in certain circumstances.
Human Genome Sciences plans to use the … .
General corporate purposes.
Human Genome Sciences develops pharmaceutical products to predict, prevent … William A. Haseltine, CEO, Human Genome Sciences, 9410 Key West Ave., …
-
Rectify Pharmaceuticals Appoints Sachiyo Minegishi as Chief Operating Officer
25 Apr 2023 11:15 GMT
Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company … held leadership roles at Aegerion Pharmaceuticals, Human Genome Sciences, Genzyme, and Amgen. She began … into the clinic.”
About Rectify Pharmaceuticals, Inc. (“Rectify”)
Rectify is …
-
InterAx Biotech Announces the Appointment of Seasoned Pharmaceutical Executive, Dr. Christopher Prior, as CEO and Reports Recent Drug Discovery Highlights
25 Jan 2023 01:47 GMT
… at Aventis (now Sanofi), Pfizer, Human Genome Sciences (now GSK) and Biogen. Dr … -Announces-the-Appointment-of-Seasoned-Pharmaceutical-Executive-Dr-Christopher-Prior-as …
-
Checkmate Pharmaceuticals Announces Key Additions to Executive Management Team
04 Jan 2021 21:30 GMT
… 2021 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate … President, Finance and Treasury at Human Genome Sciences, Inc., which was acquired … University. About Checkmate Pharmaceuticals Checkmate Pharmaceuticals is a clinical stage …
-
GSK to acquire Human Genome Sciences for US$14.25 per share in cash
16 Jul 2012 14:12 GMT
… plc (LSE: GSK) and Human Genome Sciences (NASDAQ: HGSI) today announced … world’s leading research-based pharmaceutical and healthcare companies – is … com . HGS, Human Genome Sciences and BENLYSTA ® are trademarks of Human Genome Sciences, Inc. Other …
-
Graphite Bio Appoints Pharmaceutical Industry Veterans to Board of Directors
21 Dec 2020 15:22 GMT
… executive officer (CEO) of Swiss pharmaceutical company Novartis, and Perry Karsen … of the world’s leading pharmaceutical companies. Mr. Jimenez joined … has held executive positions at Human Genome Sciences, Inc., a biopharmaceutical company subsequently …